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BRIEF COMMUNICATION
CTX-M-1 and CTX-M-15-producing 
Escherichia coli in dog faeces from public 
gardens
Peter Damborg1*, Malene Kjelin Morsing1, Tanja Petersen1, Valeria Bortolaia1 and Luca Guardabassi1,2
Abstract 
Background: Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli are increasingly reported in dogs. 
The objective of this study was to provide data on the prevalence of ESBL-producing E. coli in dog faecal deposits in 
public gardens.
Results: A total of 209 faecal deposits collected in nine public gardens in Copenhagen, Denmark were screened by 
selective enrichment followed by plating on MacConkey agar supplemented with cefotaxime. Presumptive ESBL-
producing E. coli were confirmed by MALDI-TOF MS and polymerase chain reaction (PCR) for detection of common 
cefotaxime resistance determinants (blaTEM, blaSHV, blaCTX-M and blaCMY-2). ESBL-producers were further characterized 
by multilocus sequence typing (MLST) and antimicrobial susceptibility testing using broth microdilution. Plasmids 
harbouring ESBL genes were characterized by S1 nuclease pulsed field gel electrophoresis, PCR-based replicon typing, 
and pMLST. Cefotaxime-resistant E. coli were detected in four (1.9 %) samples. Three samples harboured CTX-M-1-pro-
ducing isolates, and one sample contained two CTX-M-15-producing isolates displaying distinct colony morphology. 
All isolates belonged to distinct sequence types (STs), including one E. coli lineage previously associated to a human-
specific pathotype (ST59). blaCTX-M-1 was carried on IncI1 plasmids classified as ST3 or ST58 by pMLST, whereas blaCTX-
M-15 was located on IncF/Y and non-typeable plasmids in the two strains isolated from the same sample.
Conclusions: The study shows that dog faeces are a vector for dissemination of CTX-M-producing E. coli within 
urban areas. The risk derived from human exposure to dog faeces in public gardens depends on the prevalence of 
these bacteria in the local dog population as well as on the owners’ practice to remove and dispose their dog’s faeces.
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Findings
The rapid emergence of extended-spectrum beta-lac-
tamase (ESBL)-producing Escherichia coli in the com-
munity has prompted search for sources in the animal 
population. Food animals are a well-studied animal reser-
voir, but companion animals, in particular dogs, may also 
be colonised or infected with these cephalosporin-resist-
ant E. coli [1]. The prevalence of ESBL carriage in dogs 
varies considerably between countries with the highest 
frequency (55 %) being reported in diarrheic dogs in The 
Netherlands [2]. Faecal shedding of ESBL-producing E. 
coli by dogs was recently shown to be highly dynamic 
with the majority of dogs being intermittent shedders 
and positive for different ESBL genes over time [3]. The 
most common ESBL type found in canine E. coli is CTX-
M, which also predominates in humans and other ani-
mals including livestock and wild animals [1, 4, 5].
The close contact between dogs and humans implies 
risks of zoonotic transmission for a variety of pathogens, 
especially by the faecal-oral route [6]. Dog faeces are a 
recognized source of zoonotic agents, including clini-
cally relevant resistant bacteria that can be transmitted to 
humans through direct exposure or via contamination of 
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domestic and public environments. The objective of this 
study was to provide data on the prevalence and types of 
ESBL-producing E. coli in dog faecal deposits in public 
gardens.
In April and May 2013, 209 faecal samples were col-
lected from trashcans in nine public gardens (5–40 sam-
ples per park) in the Greater Copenhagen area, Denmark. 
All samples were contained in plastic bags and suppos-
edly less than 2 days old, since trashcans in these gardens 
are emptied at least every other day by the municipality. 
Each garden was visited only once to limit the risk of get-
ting more than one sample per dog.
Samples were processed in the laboratory on the day 
of collection. One gram of each sample was suspended 
1:10 in MacConkey broth (Oxoid, Basingstoke, UK) sup-
plemented with 1  mg/l cefotaxime. Following overnight 
incubation with shaking at 37 °C, 10 µl of the enrichment 
culture was plated onto MacConkey agar (Oxoid) con-
taining 1 mg/l cefotaxime. After incubation (24 h, 37 °C), 
one presumptive E. coli was sub-cultured from samples 
displaying growth and stored at −80  °C prior to further 
analyses. Multiple colonies were stored if more than one 
colony morphology was visible on the same plate.
Presumptive E. coli isolates were confirmed by matrix-
assisted laser desorption ionization-time of flight 
(MALDI-TOF) mass spectrometry (Vitek MS RUO; 
bioMérieux, France) using E. coli ATCC 8739 as refer-
ence strain and Saramis™ 3.5 (bioMérieux) for spectra 
interpretation. Antibiotic susceptibility was tested by 
broth microdilution using Sensititre COMPAN1F plates 
(Thermo Fisher Scientific, Hvidovre, Denmark). Sus-
ceptibility to amoxicillin clavulanate, cefoxitin, cefpo-
doxime, imipenem, and the non-beta-lactams amikacin, 
chloramphenicol, doxycycline, enrofloxacin, gentamicin, 
marbofloxacin, and sulfamethoxazole/trimethoprim was 
interpreted according to the Clinical and Laboratory 
Standards Institute guidelines [7].
Genes encoding the most common ESBL types (blaCTX-
M, blaTEM and blaSHV) and plasmid-encoded AmpC 
beta-lactamase (blaCMY-2) were detected by polymerase 
chain reaction (PCR) and sequenced [8, 9]. Positive iso-
lates were characterized by multilocus sequence typing 
(MLST) and assigned to sequence types (STs) using the 
E. coli MLST database (http://mlst-warwick.ac.uk).
Plasmid DNA purified by alkaline lysis was transformed 
into electrocompetent Genehog E. coli (Invitrogen, 
Carlsbad, USA) followed by selection of transformants 
on Müller Hinton agar (Oxoid, Basingstoke, UK) sup-
plemented with 1  mg/l cefotaxime. Transformants veri-
fied by colony PCR were subjected to S1 nuclease pulsed 
field gel electrophoresis (PFGE) [10], PCR-based replicon 
typing (PBRT) (Diatheva, Fano, Italy), and antimicrobial 
susceptibility testing (as described above). IncI1 plasmids 
were subtyped by plasmid MLST (pMLST) [11].
Four faecal deposits (1.9  %) collected in two gardens 
displayed growth of lactose-positive colonies, and addi-
tional growth of lactose-negative colonies was detected 
in one of these samples. All colonies were identified 
as E. coli and harboured one or more genes encod-
ing β-lactamase, namely blaCTX-M-1 (n  =  3), blaCTX-
M-15 (n = 2) and blaTEM-1 (n = 2) (Table 1). Each isolate 
belonged to a distinct genotype (ST59, ST609, ST4304, 
ST4305 or ST4340). The five strains were resistant to 
cefpodoxime and susceptible to amoxicillin clavulanate, 
cefoxitin, aminoglycosides and chloramphenicol. Suscep-
tibility to fluoroquinolones, sulfamethoxazole/trimetho-
prim and doxycycline varied depending on the strain 
(Table 1).
Plasmids carrying ESBL genes varied from approxi-
mately 78 to 104  Kb. blaCTX-M-1 was found in three 
strains on IncI1 plasmids assigned to ST58 (n  =  2) or 
ST3 (n = 1) by pMLST. blaCTX-M-15 was detected in the 
lactose-positive and the lactose-negative isolates from 
the same sample on distinct plasmids, one positive for 
both the FIB and the Y replicon types, and the other one 
non-typeable by PBRT. Resistance to sulfamethoxazole 
and trimethoprim was co-transferred by the two plas-
mids IncI1 ST3 and FIB/Y (Table 1).
The observed prevalence of 1.9  % ESBL-producing 
E. coli in dog faecal deposits is generally lower than 
reported in healthy dogs in other European studies [2, 
12, 13]. This difference may indicate a low prevalence of 
ESBL-producing E. coli in the Danish dog population but 
could also be due to differences in study population, sam-
ple collection or processing. In fact, most other studies 
reported on fresh samples obtained directly from dogs. 
The high local variation with most ESBL-positive samples 
deriving from public garden B (Table  1) may reflect the 
relatively high number of samples (n =  40) collected in 
this garden, but otherwise is difficult to explain given the 
close proximity of the gardens (within a 7  km diameter 
zone) and the common municipal practice for emptying 
of waste bins. One recent study detected ESBL or AmpC-
producing E. coli in 14 % of faecal deposits collected near 
a small animal hospital in Germany [14]. This high prev-
alence was likely influenced by the study location and 
associated antimicrobial selective pressure, since some 
clones were also detected in hospitalized dogs. Both that 
and the present study found a clear predominance of 
blaCTX-M-1 and blaCTX-M-15 among isolates, thus confirm-
ing previous evidence that these ESBL-types are the most 
frequent in dogs in Europe [1, 3, 15]. The ESBLs were 
found in different E. coli genetic backgrounds, including 
three newly described STs (ST4304, ST4305 and ST4340) 
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and one genotype (ST59) that has previously been associ-
ated to a human-specific pathotype [16]. Our failure to 
detect CMY-2 was however unexpected, as this plasmid-
mediated AmpC β-lactamase is frequent among cepha-
losporin-resistant E. coli isolated from dogs in Denmark 
[17] as well as in other EU countries [18] and continents 
[19–21].
The association of blaCTX-M-1 with IncI1 plasmids is 
well known in E. coli from humans and several animal 
species across Europe. Within this incompatibility group, 
ST3 plasmids harbouring blaCTX-M-1 have been reported 
in different animal species in Denmark, France, Switzer-
land and Tunisia [13, 22–25], suggesting that this specific 
IncI1 plasmid lineage has no geographic or host barri-
ers. The other IncI1 plasmid detected in association with 
blaCTX-M-1 (ST58) plasmids is less frequently reported but 
was recently described in human CTX-M-1-producing E. 
coli isolates from Danish patients [24].
CTX-M-15 is the most frequent ESBL type in human 
clinical E. coli isolates in most EU countries, often in 
association with IncF plasmids [4]. We found blaCTX-M-15 
on IncFIB/IncY and non-typeable plasmids in two geneti-
cally distinct E. coli strains originating from the same 
sample (Table  1). Multireplicon plasmid IncFIB/IncY 
have not been reported previously, although another 
hybrid replicon (IncY/IncA/C) was described in asso-
ciation with blaCTX-M-15 in Salmonella Concord isolated 
from humans in France [26]. Our results suggest that the 
dog from which the sample derived had been exposed to 
CTX-M-15-producing E. coli on at least two occasions 
or that recombination took place between different plas-
mids and strains. This second hypothesis is supported by 
the fact that the IncY replicon is also found on phages, 
and several plasmids non-typeable by PBRT in E. coli are 
indeed phages [27].
A limitation of the study is that samples were inside 
plastic bags upon collection and therefore not fully repre-
senting the faecal deposits that people may encounter on 
the ground. However, we deliberately chose this sampling 
strategy to minimize the risk of collecting samples from 
the same dog more than once.
The study shows that dog faeces are a vector for dis-
semination of CTX-M-producing E. coli within urban 
areas. The risk derived from human exposure to dog fae-
ces in public gardens is highlighted by the isolation of E. 
coli and plasmid lineages previously detected in human 
infections. This risk appears to be low in Copenhagen but 
could be significantly higher in other geographical areas 
where these bacteria are prevalent in the dog population 
and the practice of removing and disposing dog faeces is 
not well established among dog owners. In view of this 
and the potential for other zoonotic pathogens in dog 
faeces [6], owners should be encouraged to dispose dog 
faecal deposits and to practice hand hygienic procedures 
afterwards, for example by using a hand rub disinfectant.
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Table 1 Genotypic and phenotypic features of cefotaxime-resistant Escherichia coli isolated from dog faecal deposits
ENR enrofloxacin, DOX doxycycline, MAR marbofloxacin, SXT sulfamethoxazole/trimethoprim, NA not applicable
a Lactose-negative strain
b Lactose-positive strain
Strain ID Public 
garden
Faecal 
deposit
Cefotaxime-resistant E. coli CTX-M-encoding plasmid
bla gene(s) Resistance 
to non- 
beta-lactams
MLST type Replicon(s) pMLST  
type
Size (kb) Co-transferred 
resistance
147 A 1 blaCTX-M-1 None ST59 I1 ST58 78 None
115 B 2 blaCTX-M-1 SXT ST4340 I1 ST58 78 None
122 B 3 blaCTX-M-1 
blaTEM-1
DOX, SXT ST4304 I1 ST3 104 SXT
104ga B 4 blaCTX-M-15 ENR, MAR ST4305 Non-typeable NA 104 None
104rb B 4 blaCTX-M-15 
blaTEM-1
DOX, SXT ST609 FIB, Y NA 95 SXT
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